Eradication rates of Helicobacter pylori in treatment‐naive patients following 14‐day vonoprazan‐amoxicillin dual therapy: A multicenter randomized controlled trial in China

Background Potassium‐competitive acid blockers (P‐CAB) are recommended for the treatment of Helicobacter pylori infections, but dual therapy of P‐CAB with amoxicillin has been poorly studied. The current study compared the efficacy, adverse reactions, compliance, and effects on gut microbiota of 14‐...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Helicobacter (Cambridge, Mass.) Mass.), 2023-08, Vol.28 (4), p.e12970-n/a
Hauptverfasser:	Hu, Jie, Mei, Hao, Su, Na‐yun, Sun, Wen‐jing, Zhang, De‐kui, Fan, Li‐lin, He, Ping, Pan, Jie, Wang, Xing‐wei, Zou, Pei‐ying, Liu, Yu‐xiang, Guo, Yan, Lan, Chun‐Hui
Format:	Artikel
Sprache:	eng
Schlagworte:	Amoxicillin bacterial infection Bismuth Breath tests Eradication Feces Helicobacter pylori Intestinal microflora Metagenomics Metronidazole Microbiota Microorganisms Omeprazole Patient compliance Penicillin Potassium rRNA 16S Side effects Therapy Urea vonoprazan
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!